The generic name for Mirabegron is mirabegron [1].
When did the Mirabegron patent expire?
The primary patents for Mirabegron, marketed as Myrbetriq and Betanis, have expired in the United States. For example, U.S. Patent No. 8,710,061, which covers certain crystalline forms of mirabegron, expired on December 10, 2024 [2].
What companies are making generic Mirabegron?
Following patent expirations, several pharmaceutical companies are producing or preparing to produce generic versions of mirabegron. These include manufacturers like Dr. Reddy's Laboratories, Aurobindo Pharma, and Teva Pharmaceuticals [1].
How much does generic Mirabegron cost?
The cost of generic mirabegron is typically lower than the branded versions, Myrbetriq and Betanis. Prices can vary depending on the pharmacy and insurance coverage, but generics generally offer significant savings [3].
What is Mirabegron used to treat?
Mirabegron is a medication used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency [1].
How does Mirabegron work?
Mirabegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle in the bladder, which allows the bladder to hold more urine and reduces the sudden urge to urinate [1].
What are the side effects of Mirabegron?
Common side effects of mirabegron can include high blood pressure, urinary tract infections, constipation, and headache. Less common but more serious side effects can also occur [1].
Are there alternatives to Mirabegron?
Yes, there are alternative treatments for overactive bladder, including other medications like anticholinergics, behavioral therapies, and surgical options [1].
What is the difference between Myrbetriq and Betanis?
Myrbetriq and Betanis are both brand-name formulations of mirabegron. Betanis is the brand name in Europe, while Myrbetriq is the brand name in the United States. They contain the same active ingredient and are used for the same indications [1].
Can generic Mirabegron be prescribed before patent expiry?
Generally, generic versions are only legally available for prescription after the relevant patents and market exclusivities have expired. This is to protect the innovation of the original drug developer [4].
Sources:
1. https://www.drugpatentwatch.com/drug/mirabegron
2. https://www.drugpatentwatch.com/patent/us8710061/mirabegron
3. https://www.drugpatentwatch.com/generic-drug/mirabegron
4. https://www.drugpatentwatch.com/